BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37964984)

  • 1. Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma.
    Ma Y; Zheng S; Xu M; Chen C; He H
    Stem Cells Int; 2023; 2023():6245160. PubMed ID: 37964984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer.
    Yuan J; Duan F; Zhai W; Song C; Wang L; Xia W; Hua X; Yuan Z; Bi X; Huang J
    Int J Womens Health; 2021; 13():1053-1064. PubMed ID: 34785957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma.
    Zhai WY; Duan FF; Chen S; Wang JY; Zhao ZR; Wang YZ; Rao BY; Lin YB; Long H
    Front Cell Dev Biol; 2022; 10():770550. PubMed ID: 35300428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
    Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
    J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
    Li J; Qi C; Li Q; Liu F
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
    Xu Q; Chen Y
    Front Cell Dev Biol; 2021; 9():685379. PubMed ID: 34277626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Development of an Age-Related Classification and Signature to Predict Prognosis and Immune Landscape in Osteosarcoma.
    Hong J; Wang X; Yu L; Li J; Hu H; Mao W
    J Oncol; 2022; 2022():5040458. PubMed ID: 36276293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer.
    Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L
    Front Genet; 2023; 14():1186862. PubMed ID: 37323657
    [No Abstract]   [Full Text] [Related]  

  • 11. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
    Yan C; Liu Q; Jia R
    Front Oncol; 2022; 12():829045. PubMed ID: 35186763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma.
    Xue S; Ge W; Wang K; Mao T; Zhang X; Xu H; Wang Y; Yao J; Li S; Yue M; Ma J; Wang Y; Shentu D; Cui J; Wang L
    Front Cell Dev Biol; 2022; 10():942225. PubMed ID: 36003146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel signature of aging-related genes associated with lymphatic metastasis for survival prediction in patients with bladder cancer.
    Zhu Z; Li X; Liu D; Li Z
    Front Oncol; 2023; 13():1140891. PubMed ID: 37441420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.
    Zhong S; Chen H; Yang S; Feng J; Zhou S
    PeerJ; 2020; 8():e9621. PubMed ID: 33194339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.